Rethinking Fluoride: FDA Takes a Stand for Kids’ Health

The U.S. Food and Drug Administration (FDA) has taken the initiative to stop the use of concentrated ingestible fluoride present in prescription drugs of children. Toddlers or infants ingesting these types of products has never been approved by the FDA as it puts great risk of damaging the natural gut microbiome in the early life of these toddlers and infants, along with studies showing it can lead to thyroid disorders, weight gain and chance of lower IQ.

FDA Commissioner Dr. Marty Makary stated that preventing cavities in children should focus on reducing sugar intake and maintaining proper dental hygiene, rather than altering the gut microbiome. He expressed concern that ingested fluoride may affect beneficial intestinal bacteria and has requested a review to better assess the potential risks and ensure the safety of pediatric use.

The FDA has set a target date of October 31 to complete its safety review, gather public feedback, and take suitable action on the elimination of ingestible fluoride products from the market. Alongside this, the U.S. Department of Health and Human Services will issue guidelines promoting effective, practical dental hygiene for children that do not impact gut health.

This act follows similar efforts in several U.S. states and reflects global trends, as most countries, including many in Europe, do not add fluoride to drinking water.

Learn more: FDA Begins Action To Remove Ingestible Fluoride Prescription Drug Products for Children from the Market | FDA